Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GORTEC 2000-01: TPF vs PF Induction Chemotherapy for Larynx Preservation
NCT00169182Phase 3Completed
- Sponsor
- GORTEC
- Start
- Dec 2001
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in laryngeal cancer, Hypopharyngeal cancer, sponsored by GORTEC. Started Dec 2001; status: completed.
02
Drugs
docetaxel
03
Conditions
laryngeal cancerHypopharyngeal cancer
Beyond the preview
Go deeper on NCT00169182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169182.